23 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2034. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2034
Next term end
6
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2034 · High confidence
Also notable
Ends Mar 2034 · High confidence
Also notable
Ends Dec 2041 · High confidence
Compositions and Methods for the Treatment of Presbyopia
US 10,064,818
Cited by 27 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Compositions and Methods for the Treatment of Presbyopia
US 11,273,150
Cited by 6 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Compositions and Methods for the Treatment of Presbyopia
US 11,648,247
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2041.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 4, 2026The maintenance fee for Contact Lens Compositions and Methods for the Treatment of Presbyopia (US 10,307,408) comes due Dec 4, 2026. Unpaid by Jun 4, 2027, it lapses early.
- 1 fee due Jan 28, 2027The maintenance fee for Compositions and Methods for the Treatment of Presbyopia (US 9,089,562) comes due Jan 28, 2027. Unpaid by Jul 28, 2027, it lapses early.
- 3 fees due Oct 14 to 26, 2027 · next Oct 14
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 4 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Compositions and Methods for the Treatment of Presbyopia (2014) | 15 in force | to Jun 2035 |
| Compositions and Methods for the Treatment of Presbyopia (2019) | 4 in force | to Oct 2039 |
| Compositions, Methods, and Systems in Treating Presbyopia | 1 in force | to Mar 2044 |
| Compositions and Methods for the Treatment of Presbyopia (2021) | 1 in force | to Dec 2041 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,089,562 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 9,314,427 | Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye In force · High confidence | In force | High confidence | |
| US 9,320,709 | Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye In force · High confidence | In force | High confidence | |
| US 9,833,441 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 9,844,537 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 9,968,594 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 10,052,313 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 10,064,818 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 10,307,408 | Contact Lens Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence | |
| US 10,617,763 | Compositions and Methods for the Treatment of Presbyopia In force · High confidence | In force | High confidence |
Also on record, not counted in the 23: 9 applications pending · 18 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.